Clinical trial

Pakistan Study of Premature Coronary Atherosclerosis in Young Adults

NCT05156736

Drugs and interventions used in this trial

0 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

No interventions are currently published for this study in CureCurrent. View the original registry record below.

Study at a glance

Registry-backed

Pakistan Study of Premature Coronary Atherosclerosis in Young Adults

Design: OBSERVATIONAL · Status: RECRUITING · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusRECRUITING

Study typeOBSERVATIONAL

Start date2023-03-15

PhaseN/A

Conditions

Atherosclerotic Plaqueunresolved

Diabetes Mellitus, Type 2verified · MONDO: type 2 diabetes mellitus

Hypertensionunresolved

Strokeverified · MONDO: stroke disorder

Interventions

Sponsors & collaborators

Tabba Heart Institutelead sponsor

Getz Pharmacollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05156736 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.